Adenoviral Insulin Gene Therapy Prolongs Survival of IDDM Model BB Rats by Improving Hyperlipidemia

Abstract

Diabetes is frequently associated with hyperlipidemia, which results in atherogenic complications. Insulin-dependent diabetes mellitus (IDDM) model BB/Wor//Tky (BB) rats exhibit both hyperglycemia and hyperlipidemia and die within 3 weeks after the onset of diabetes unless insulin therapy is given. We performed insulin gene therapy in BB rats with adenovirus vectors through the tail vein. After infusion, plasma triglyceride levels dropped quickly and maintained low levels for 1 week, whereas blood glucose levels showed a slight decrease. The survival period of diabetic BB rats was prolonged to up to 75 days by infusing insulin gene-expressing adenoviral vectors. We suggest that the control of hyperlipidemia can be a life-saving measure when combined with hyperglycemia control in the treatment of diabetes.

Insulin Gene Therapy - IDDM Model BB Rats - Hyperlipidemia - Hypertriglyceridemia - Hyperglycemia - Adenoviral Gene Delivery

References

• 1 Kolodka T M, Finegold M, Moss L, Woo S LC. Gene therapy for diabetes mellitus in rats by hepatic expression.  Proc Natl Acad Sci USA. 1995;  92 3293-3297
• 2 Muzzin P, Eisensmith R C, Copeland K C, Woo S LC. Hepatic insulin gene expression as treatment for type 1 diabetes mellitus in rats.  Mol Endocrinol. 1997;  11 833-837
• 3 Chen R, Meseck M L, Woo S LC. Auto-regulated hepatic insulin gene expression in type 1 diabetic rats.  Mol Ther. 2001;  3 584-590
• 4 Short D K, Okada S, Ymamauchi K, Pessin J E. Adenovirus-mediated transfer of a modified human proinsulin gene reverses hyperglycemia in diabetic mice.  Am J Physiol. 1998;  275 E748-E756
• 5 Yin D, Tang J-G. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.  FEBS Lett. 2001;  495 16-20
• 6 Lee H C, Kim S-J, Kim K-S, Shin H-C, Yoon J-W. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue.  Nature. 2000;  408 483-438
• 7 Thulé P M, Liu J-M. Regulated hepatic insulin gene therapy of STZ-diabetic rats.  Gene Ther. 2000;  7 1744-1752
• 8 Junod A, Lambert A E, Stauffacher W, Renold A E. Diabetogenic action of streptozotocin: relationship of dose to metabolic response.  J Clin Invest. 1969;  48 2129-2139
• 9 Morishita R, Gibbons G H, Kaneda Y, Ogihara T, Dzau V J. Systemic administration of HVJ viral coat-liposome complex containing human insulin vector decreases glucose level in diabetic mouse: a model of gene therapy.  Biochem Biophys Res Commun. 2000;  273 666-674
• 10 Dheen S T, Tay S SW, Wong W C. Localization of insulin-like immunoreactive neurons in the hypothalamic paraventricular and supraoptic nuclei of streptozotocin-induced diabetic rats.  J Brain Res. 1994;  35 487-494
• 11 Like A A, Butleer L, Williams R M, Appel M C, Weringer E J, Rossini A A. Spontaneous autoimmune diabetes mellitus in the BB rat.  Diabetes. 1982;  31 7-13
• 12 Lu D, Hoshino H, Takeuchi T. Regulatable production of mature insulin from a hepatocyte cell line: insulin production is up-regulated by cAMP and glucocorticoids, and down-regulated by insulin.  FEBS Lett. 1996;  399 37-42
• 13 Lu D, Tamemoto H, Shibata H, Saito I, Takeuchi T. Regulatable production of insulin from primary-cultured hepatocytes: insulin production is up-regulated by glucagon and cAMP and down-regulated by insulin.  Gene Ther. 1998;  5 888-895
• 14 Kurihara H, Zama A, Tamura M, Takeda J, Sasaki T, Takeuchi T. Glioma/glioblastoma-specific adenoviral gene expression using the nestin gene regulator.  Gene Ther. 2000;  7 686-693
• 15 Vrancken Peeters M JTFD, Patijn G A, Lieber A, Meuse L, Kay M A. Adenovirus-mediated hepatic gene transfer in mice: comparison of intravascular and biliary administration.  Hum Gene Ther. 1996;  7 1693-1699
• 16 Wang J, Takeuchi T, Tanaka S, Kubo S-K, Kayo T, Lu D, Takata K, Koizumi A, Izumi T. A mutation in the insulin 2 gene induces diabetes with severe pancreatic β-cell dysfunction in the Mody mouse.  J Clin Invest. 1999;  103 27-37
• 17 Bagdade J D, Porte D, Bierman E L. Diabetic lipemia.  N Engl J Med. 1967;  276 427-433
• 18 Ishii C, Kawazu S, Utsugi T, Ito Y, Ohno T, Kato N, Shimizu M, Tomono S, Nagai R, Komeda K. Beta-cell replication in insulin-induced remission of IDDM in BB/Wor//Tky rats.  Diabetes Res. 1996;  31 1-18
• 19 Kraemer F B, Takeda D, Natu V, Sztalryd C. Insulin regulates lipoprotein lipase activity in rat adipose cell via wortmannin- and rapamycin-sensitive pathways.  Metabolism. 1998;  47 555-559
• 20 Weinstock P H, Bisgaier C L, Aalto-Setälä K, Radner H, Ramakrishnan R, Levak-Frank S, Essenburg A D, Zechner R, Breslow J L. Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice.  J Clin Invest. 1995;  96 2555-2568
• 21 Nagamatsu S, Nakauchi Y, Ohara-Imaizumi M, Ozawa S, Katahira H, Watanabe T, Ishida H. Adenovirus-mediated preproinsulin gene transfer into adipose tissues ameliorates hyperglycemia in obese diabetic KKA^γ mice.  FEBS Lett. 2001;  509 106-110